| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.461 | 0.054 | 0.462 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.462 0.054 CID_71366829 | CID_71366829 | |
| 0.389 | 0.029 | 0.389 | Tumour necrosis factor alpha release inhibitor | 0.351 0.038 CID_71366829 | ||
| 0.365 | 0.026 | 0.365 | Peroxidase inhibitor | 0.131 0.09 CID_71366829 | ||
| 0.354 | 0.035 | 0.354 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.264 0.093 CID_71366829 | ||
| 0.314 | 0.02 | 0.314 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.277 0.039 CID_71366829 | ||
| 0.357 | 0.082 | 0.405 | GABA C receptor rho-3 antagonist | 0.405 0.059 CID_71366829 | CID_71366829 | |
| 0.303 | 0.029 | 0.303 | MAP-kinase-activated kinase 5 inhibitor | 0.272 0.046 CID_71366829 | ||
| 0.352 | 0.091 | 0.352 | MAP kinase kinase 6 inhibitor | 0.275 0.16 CID_71366829 | ||
| 0.268 | 0.018 | 0.268 | MAP kinase kinase 3 inhibitor | 0.247 0.035 CID_71366829 | ||
| 0.244 | 0.016 | 0.244 | MAP kinase kinase inhibitor | 0.192 0.031 CID_71366829 | ||
| 0.247 | 0.027 | 0.247 | Heat shock protein 90 alpha antagonist | 0.131 0.11 CID_71366829 | ||
| 0.266 | 0.057 | 0.368 | Pyruvate kinase inhibitor | 0.368 0.028 CID_71366829 | CID_71366829 | |
| 0.227 | 0.02 | 0.227 | Death-associated protein kinase 2 inhibitor | |||
| 0.226 | 0.028 | 0.226 | Heat shock protein 90 antagonist | 0.124 0.106 CID_71366829 | ||
| 0.215 | 0.017 | 0.215 | MAP kinase 3 inhibitor | |||
| 0.148 | 0.012 | 0.148 | Cyclin-dependent kinase 4 inhibitor | 0.087 0.031 CID_71366829 | ||
| 0.195 | 0.071 | 0.195 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.142 CID_71366829 | ||
| 0.149 | 0.024 | 0.149 | Transcription factor STAT6 inhibitor | 0.105 0.093 CID_71366829 | ||
| 0.155 | 0.032 | 0.155 | Death-associated protein kinase 1 inhibitor | |||
| 0.114 | 0.009 | 0.114 | AMPA receptor antagonist | 0.046 0.035 CID_71366829 | ||
| 0.131 | 0.048 | 0.135 | GABA receptor agonist | 0.135 0.045 CID_71366829 | CID_71366829 | |
| 0.178 | 0.096 | 0.178 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.14 | 0.061 | 0.14 | Cyclin-dependent kinase inhibitor | 0.126 0.07 CID_71366829 | ||
| 0.159 | 0.089 | 0.159 | Tumour necrosis factor antagonist | 0.132 0.124 CID_71366829 | ||
| 0.082 | 0.02 | 0.082 | Cyclin-dependent kinase 6 inhibitor | 0.059 0.042 CID_71366829 | ||
| 0.083 | 0.021 | 0.083 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.165 | 0.107 | 0.165 | Focal adhesion kinase 2 inhibitor | 0.158 0.118 CID_71366829 | ||
| 0.115 | 0.058 | 0.115 | GABA C receptor antagonist | |||
| 0.142 | 0.086 | 0.156 | GABA C receptor rho-2 antagonist | 0.156 0.065 CID_71366829 | CID_71366829 | |
| 0.086 | 0.033 | 0.086 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.062 | 0.01 | 0.062 | Histone deacetylase class II inhibitor | |||
| 0.111 | 0.064 | 0.119 | Acetylcholine release stimulant | 0.119 0.05 CID_71366829 | CID_71366829 | |
| 0.074 | 0.028 | 0.074 | CDK4/cyclin D1 inhibitor | |||
| 0.13 | 0.085 | 0.13 | Activin receptor-like kinase 2 inhibitor | |||
| 0.091 | 0.047 | 0.092 | GABA A receptor agonist | 0.092 0.045 CID_71366829 | CID_71366829 | |
| 0.108 | 0.065 | 0.108 | Protein kinase C gamma inhibitor | |||
| 0.051 | 0.011 | 0.051 | Histone deacetylase class IIb inhibitor | |||
| 0.05 | 0.011 | 0.05 | Histone deacetylase 6 inhibitor | |||
| 0.054 | 0.015 | 0.054 | Histone deacetylase 5 inhibitor | |||
| 0.045 | 0.009 | 0.045 | CDK6/cyclin D3 inhibitor | 0.036 0.019 CID_71366829 | ||
| 0.157 | 0.124 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.189 | 0.158 | 0.189 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.12 | 0.09 | 0.12 | Ribosomal protein S6 kinase inhibitor | |||
| 0.07 | 0.04 | 0.07 | Histone deacetylase inhibitor | |||
| 0.103 | 0.073 | 0.103 | CDC-like kinase 3 inhibitor | |||
| 0.075 | 0.047 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.043 | 0.016 | 0.043 | Histone deacetylase class IIa inhibitor | |||
| 0.043 | 0.017 | 0.043 | Histone deacetylase 2 inhibitor | |||
| 0.039 | 0.013 | 0.039 | Histone deacetylase 1 inhibitor | |||
| 0.104 | 0.084 | 0.104 | Alkylator | |||
| 0.081 | 0.061 | 0.081 | MAP-kinase-activated kinase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase 11 inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase class IV inhibitor | |||
| 0.074 | 0.054 | 0.074 | CYP2A6 inhibitor | |||
| 0.037 | 0.019 | 0.037 | ADAM10 endopeptidase inhibitor | |||
| 0.152 | 0.134 | 0.152 | Dyrk kinase inhibitor | |||
| 0.11 | 0.093 | 0.11 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.058 | 0.041 | 0.058 | CDK4/cyclin D inhibitor | |||
| 0.066 | 0.051 | 0.066 | MAP kinase kinase 8 inhibitor | |||
| 0.035 | 0.02 | 0.035 | Histone deacetylase 4 inhibitor | |||
| 0.053 | 0.039 | 0.053 | GABA receptor antagonist | |||
| 0.086 | 0.073 | 0.086 | Protein kinase C mu inhibitor | |||
| 0.146 | 0.134 | 0.146 | EphB2 antagonist | |||
| 0.031 | 0.02 | 0.031 | Histone deacetylase 10 inhibitor | |||
| 0.046 | 0.034 | 0.046 | Adenosine deaminase inhibitor | |||
| 0.081 | 0.071 | 0.081 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.032 | 0.023 | 0.032 | Protein kinase C beta II inhibitor | |||
| 0.037 | 0.029 | 0.037 | Vascular adhesion protein 1 inhibitor | |||
| 0.049 | 0.042 | 0.049 | GABA A receptor antagonist | |||
| 0.121 | 0.115 | 0.121 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.093 | 0.087 | 0.096 | Glycogen synthase kinase-3 beta inhibitor | 0.096 0.083 CID_71366829 | CID_71366829 | |
| 0.102 | 0.097 | 0.15 | Cyclooxygenase 1 inhibitor | 0.15 0.056 CID_71366829 | CID_71366829 | |
| 0.052 | 0.049 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.021 | 0.019 | 0.021 | Histone deacetylase 3 inhibitor | |||
| 0.05 | 0.049 | 0.05 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.086 | 0.094 | 0.104 | Glycogen synthase kinase-3 inhibitor | 0.104 0.075 CID_71366829 | CID_71366829 | |
| 0.113 | 0.123 | 0.143 | Insulin secretagoues | 0.143 0.082 CID_71366829 | CID_71366829 | |
| 0.057 | 0.072 | 0.065 | Glutamate (mGluR7) antagonist | 0.065 0.053 CID_71366829 | CID_71366829 | |
| 0.073 | 0.094 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.073 CID_71366829 | CID_71366829 | |
| 0.1 | 0.125 | 0.131 | Cyclooxygenase inhibitor | 0.131 0.086 CID_71366829 | CID_71366829 | |
| 0.087 | 0.126 | 0.112 | Cyclooxygenase 2 inhibitor | 0.112 0.089 CID_71366829 | CID_71366829 | |
| 0.119 | 0.172 | 0.164 | Non-steroidal antiinflammatory agent | 0.164 0.1 CID_71366829 | CID_71366829 | |
| 0.07 | 0.146 | 0.122 | MAP kinase 12 inhibitor | 0.122 0.067 CID_71366829 | CID_71366829 | |
| 0.199 | 0.335 | 0.463 | Antiinflammatory | 0.463 0.104 CID_71366829 | CID_71366829 | |
| 0.062 | 0.226 | 0.122 | Interleukin 1 antagonist | 0.122 0.086 CID_71366829 | CID_71366829 | |
| 0.035 | 0.213 | 0.124 | Cyclin-dependent kinase 5 inhibitor | 0.124 0.056 CID_71366829 | CID_71366829 | |
| 0.064 | 0.273 | 0.211 | Aurora-C kinase inhibitor | 0.211 0.017 CID_71366829 | CID_71366829 | |
| 0.027 | 0.257 | 0.255 | Topoisomerase I inhibitor | 0.255 0.016 CID_71366829 | CID_71366829 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |